Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $7.51 Million - $10.9 Million
-83,903 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$70.23 - $144.31 $428,192 - $879,858
-6,097 Reduced 6.77%
83,903 $8.39 Million
Q4 2019

Feb 14, 2020

SELL
$76.41 - $117.54 $1.74 Million - $2.67 Million
-22,708 Reduced 20.15%
90,000 $10.6 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $2.39 Million - $3.53 Million
-38,777 Reduced 25.6%
112,708 $9.69 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $8.79 Million - $10.1 Million
151,485 New
151,485 $9.82 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $132M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Parian Global Management LP Portfolio

Follow Parian Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Parian Global Management LP with notifications on news.